Results 1 to 10 of about 330 (164)

Tumor neuroendocrino primario del conducto hepático común [PDF]

Revista de la Facultad de Ciencias Médicas de Córdoba, 2023
Los tumores neuroendocrinos (TNE) primarios de la vía biliar son extremadamente raros y representan sólo el 0.2-2% de todos los TNE gastrointestinales. Dentro del sistema biliar, la vía biliar principal es el sitio más afectado.
Rodrigo Antonio Gasque, Noelia Zaietta, María Luján Del Bueno, Julieta Saenz, Magalí Chahdi Beltrame, Emilio Gastón Quiñonez, Francisco Juan Mattera   +6 more
doaj   +2 more sources

Eritema necrolítico migratorio como manifestación de tumor neuroendocrino de páncreas. Valoración clínico-radiológica [PDF]

Revista de la Facultad de Ciencias Médicas de Córdoba, 2022
El glucagonoma es un tumor neuroendocrino de muy baja incidencia, se estima 1 caso cada 20 millones de personas por año. Típicamente, se manifiesta con un síndrome clínico que incluye una dermatosis característica denominada eritema necrolítico ...
Gonzalo Dulcich, Marcos Alejandro Mestas Nuñez, Ernestina Maria Jose Gentile   +2 more
doaj   +2 more sources

Tumor neuroendocrino de páncreas

Revista Argentina de Radiología, 2023
Pablo Chiaradia, Nebil Larrañaga, Nicolás Roccatagliata, María de Vedia, Javier Vallejos   +4 more
doaj   +2 more sources

Tumor neuroendocrino polipoide del recto

Revista de Gastroenterología de México, 2012
P. Grube-Pagola, E. Díaz-Jiménez, J.M. Troche-Gutiérrez   +2 more
doaj   +2 more sources

Tumor neuroendocrino primario del riñón [PDF]

Actas Urológicas Españolas, 2010
J Cabral Ribeiro
exaly   +7 more sources

Hallazgos en gammagrafía con análogos de la somatostatina (Tc-99m HYNIC-TOC) en metástasis sobre cuero cabelludo como debut en un tumor neuroendocrino de origen incierto

Anales de la Facultad de Medicina, 2021
Los estudios de medicina nuclear permiten en tumor neuroendocrino (TNE) de origen desconocido la búsqueda del tumor primario y estadificación de la enfermedad.
Adriana Rosales Morales, Marylin Acuña Hernández, Leonardo Cadavid Blanco   +2 more
doaj   +1 more source

MicroRNA signature and integrative omics analyses define prognostic clusters and key pathways driving prognosis in patients with neuroendocrine neoplasms

Molecular Oncology, Volume 17, Issue 4, Page 582-597, April 2023., 2023
The comprehensive characterisation of microRNA (miRNA) profiles of neuroendocrine neoplasms has identified an eight‐miRNA signature able to stratify patients into three prognostic groups. Transcriptomic data have shown that these miRNAs are associated with genes involved in PI3K–Akt and TNFα–NF‐kB signalling.
Beatriz Soldevilla, Alberto Lens‐Pardo, Paula Espinosa‐Olarte, Carlos Carretero‐Puche, Sonia Molina‐Pinelo, Carlos Robles, Marta Benavent, Lourdes Gomez‐Izquierdo, Marta Fierro‐Fernández, Patricia Morales‐Burgo, Paula Jimenez‐Fonseca, Beatriz Anton‐Pascual, Yolanda Rodriguez‐Gil, Ana Teijo‐Quintans, Anna La Salvia, Beatriz Rubio‐Cuesta, Maria C. Riesco‐Martínez, Rocio Garcia‐Carbonero   +17 more
wiley   +1 more source

Surgery for multiple endocrine neoplasia type 1‐related insulinoma: long‐term outcomes in a large international cohort

BJS (British Journal of Surgery), Volume 107, Issue 11, Page 1489-1499, October 2020., 2020
In this cohort of 96 patients with resected multiple endocrine neoplasia 1 (MEN1)‐related insulinomas, seven patients (7 per cent) developed postoperative persistent or recurrent hypoglycaemia after a median follow‐up of 8 years. The 10‐year hypoglycaemia‐free survival rate was 91 (95 per cent c.i. 80 to 96) per cent.
D. J. van Beek, S. Nell, H. M. Verkooijen, I. H. M. Borel Rinkes, G. D. Valk, (on behalf of the DutchMEN study group), M. R. Vriens, the International MEN1 Insulinoma Study Group, P. Goudet, A. Vella, D. Donegan, D. K. Bartsch, J. Manoharan, N. D. Perrier, I. Christakis, M. L. Brandi, R. Zarnegar, E. L. Postma, E. Kebebew, P. Nockel, L. Brunaud, J. D. Pasternak, W. P. Kluijfhout, C. Sturgeon, S. Giri, B. A. Bonsing, C. H. van Eijck, H. van Goor, R. H. J. de Kleine, E. J. Nieveen van Dijkum, C. H. C. Dejong   +30 more
wiley   +1 more source

Tumores neuroendocrinos del páncreas [PDF]

Revista médica de Chile, 2004
All pancreatic neuroendocrine tumors derive from Langerhans islet cells and have a low incidence. Half of them are functioning tumors that produce diverse hormones and occasionally cause serious clinical endocrine syndromes. They may be malignant, but they have a better survival, if compared to pancreatic ductal adenocarcinoma.
Burgos S J, Luis, Burgos de C., María Eugenia   +1 more
openaire   +2 more sources

Comparison of the duration of hospital stay after laparoscopic or open distal pancreatectomy: randomized controlled trial

BJS (British Journal of Surgery), Volume 107, Issue 10, Page 1281-1288, September 2020., 2020
Laparoscopic distal pancreatectomy (LDP) was compared with open distal pancreatectomy (ODP) in a randomized trial. LDP was associated with shorter hospital stay, enhanced functional recovery, and less bleeding than ODP. Shorter hospital stay with laparoscopy Background Studies have suggested that laparoscopic distal pancreatectomy (LDP) is advantageous
B. Björnsson, A. Lindhoff Larsson, C. Hjalmarsson, T. Gasslander, P. Sandström   +4 more
wiley   +1 more source